Zenith Health Care Board of Directors
Get the latest insights into the leadership at Zenith Health Care. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Mahendra Raycha | Chairman & Managing Director |
| Mr. Akshit Raycha | Joint Managing Director |
| Mrs. Neela Raycha | Non Executive Director |
| Mr. Atul Thakker | Non Executive Director |
| Mr. Rutvik Thakkar | Independent Director |
| Mr. Rajesh Sutaria | Independent Director |
| Mr. Parag Dave | Independent Director |
Zenith Health Care Share price
ZENITHHE
3.58
0.13 (3.77%)Last updated on 16 Dec, 2025 | 10:15 IST
BUYSELL
Today's High
3.60
Today's Low
3.50
52 Week Low
3.05
52 Week High
5.85
The current prices are delayed, login to your account for live prices
Login Zenith Health Care FAQs
The board at Zenith Health Care consists of experienced professionals, including Mr. Mahendra Raycha , Mr. Akshit Raycha , and others, overseeing the company’s strategic and corporate governance.
Directors at Zenith Health Care are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Mahendra Raycha is the current chairman at Zenith Health Care.
Executive directors at Zenith Health Care are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Zenith Health Care adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Zenith Health Care, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
